Spree Operandi, LP - 20 Dec 2021 Form 4 Insider Report for Spree Acquisition Corp. 1 Ltd

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Jan 2022, 17:11:29 UTC
Prior SEC filing
13 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Spree Operandi, LP By Spree Operandi GP Limited, its sole general partner; By: /s/ Jonathan Nathan, as attorney for Shay Kronfeld, Director

Key filing fact

Spree Operandi, LP filed Form 4 for Spree Acquisition Corp. 1 Ltd on 13 Jan 2022.

Key facts

  • This page summarizes Spree Operandi, LP's Form 4 filing for Spree Acquisition Corp. 1 Ltd.
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Jan 2022, 17:11.

Change

  • Previous filing in this sequence was filed on 13 Jan 2022.
  • Current net transaction value: +$9,457,150.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SHAP transaction

Units composed of 1 Class A ordinary share & 0.5 warrants

Purchase

Transaction value
$9,457,150
Shares
+945,715
Change %
Price
$10.00
Shares after
945,715
Date
20 Dec 2021
Ownership
By Spree Operandi U.S. LP
Footnotes
F1, F2, F3
SHAP holding

Class A ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,031,250
Date
20 Dec 2021
Ownership
By Spree Operandi U.S. LP
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Class A ordinary shares and warrants comprising the units are expected to begin separate trading on the 52nd day following the date of the prospectus for the Issuer's initial public offering, unless the representative of the underwriters for that offering allows earlier separate trading, which would be publicly announced by the Issuer.

Footnote F2

Spree Operandi U.S. LP purchased, in a private placement concurrent with the closing under the Issuer's initial public offering, 945,715 units, at a purchase price of $10.00 per unit.

Footnote F3

Spree Operandi U.S. LP (which purchased the units and also holds the Class A ordinary shares reported herein) is a wholly-owned subsidiary of Spree Operandi, LP (those two entities, the "Sponsor Entities"). Spree Operandi GP Limited, a company that is owned in equal part by Eran Plaut and Pureplay Investment LP (which is majority owned by Shay Kronfeld), serves as the sole general partner of each of the Sponsor Entities, and, consequently, possesses shared voting and investment power with respect to the securities reported in this row. The limited partnership interests of Spree Operandi, LP are held by various individuals and entities. Each of Messrs. Eran Plaut and Shay Kronfeld disclaims beneficial ownership of the securities reported herein other than to the extent of his indirect pecuniary interest therein.

Footnote F4

No transaction has been effected by the Reporting Persons with respect to these shares, and they are being included in this Form 4 for informational purposes only. These Class A ordinary shares are issuable on a one-for-one basis upon automatic conversion of an equivalent number of Class B ordinary shares beneficially owned by the Reporting Persons, upon consummation of the Issuer's initial business combination. Class B ordinary shares and Class A ordinary shares are generally entitled to identical economic and voting rights, with certain limited exceptions, and are therefore treated as a single class for purposes hereof. Up to 31,250 of these 5,031,250 shares are subject to forfeiture to the extent the underwriters for the Issuer's initial public offering do not exercise the remaining portion of their over-allotment option by January 29, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .